Glaxosmithkline Pharma trades in green on reporting Q4FY12 advance tax number

15 Mar 2012 Evaluate

Glaxosmithkline Pharmaceuticals is currently trading at Rs 2104.35, up by 22.65 points or 1.09% from its previous closing of Rs 2081.70 on the BSE.

The scrip opened at Rs 2089.80 and has touched a high and low of Rs 2105.00 and Rs 2076.00 respectively. So far 739 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 2475.00 on 14-Jun-2011 and a 52 week low of Rs 1830.00 on 20-Dec-2011.

Last one week high and low of the scrip stood at Rs 2105.00 and Rs 2052.35 respectively. The current market cap of the company is Rs 17702.93 crore.

The promoters holding in the company stood at 50.67% while Institutions and Non-Institutions held 32.66% and 16.67% respectively.

GlaxoSmithKline Pharmaceuticals posted a rise of 18.18% in its net profit at Rs 136.74 crore for the quarter ended December 31, 2011 as compared to Rs 115.70 crore for the same quarter in the previous year. Total income has increased by 15.35% at Rs 577.60 crore for the quarter under review as compared to Rs 500.72 crore year ago.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Glaxosmithkline Phar Share Price

2543.10 33.80 (1.35%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×